A61P 27 - Drugs for disorders of the senses

Patents for A61P 27 - Drugs for disorders of the senses (53,017)
10/1998
10/21/1998	EP0871420A1 Triacetin as a transdermal penetration enhancer
10/21/1998	CN1196676A Ophthalamic compositions containing cyclotextrins and quatemary ammonium composition
10/20/1998	US5824685 Vision defects and gene expression
10/20/1998	US5824508 Dna and amino acid sequences, vectors and host cells
10/15/1998	WO1998045332A2 Humanized antibodies and methods for forming humanized antibodies
10/15/1998	WO1998045331A2 Anti-vegf antibodies
10/15/1998	WO1998045285A1 Somatostatin agonists
10/15/1998	WO1998044922A1 Somatostatin agonists
10/15/1998	WO1998044921A1 Somatostatin agonists
10/15/1998	WO1998044915A1 In vivo polymerizable ophthalmic compositions
10/15/1998	CA2287293A1 Somatostatin agonists
10/15/1998	CA2285604A1 Somatostatin agonists
10/15/1998	CA2285223A1 Somatostatin agonists
10/15/1998	CA2272625A1 In vivo polymerizable ophthalmic compositions
10/14/1998	EP0870764A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
10/14/1998	EP0869947A1 New barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds
10/14/1998	EP0869945A1 Catechol diethers derivatives useful as pharmaceutical agents
10/14/1998	EP0869795A1 Otic microbial combinations
10/14/1998	EP0869794A1 Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
10/14/1998	EP0869782A2 METHODS OF TREATMENT WITH COMPOUNDS HAVING RAR $g(a)? RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY
10/14/1998	EP0806947A4 Formulations and methods for reducing skin irritation
10/14/1998	EP0661968B1 Pharmaceutical composition containing carbachol and other cholinergic substances
10/13/1998	US5821371 Heterocyclic compounds and their preparation and use
10/13/1998	US5821370 Muscarinic cholinergic drugs
10/13/1998	US5821366 1,3-disubsituted-zanthines to treat diseases associated with proteins that mediate cellular activity
10/13/1998	US5821227 Modulators of cytokines of the tgf β superfamily
10/13/1998	US5821123 Modified antibody variable domains
10/08/1998	WO1998044107A1 Diagnosis and prognosis of glaucoma
10/08/1998	WO1998043963A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
10/08/1998	WO1998043645A1 Inhibitors for the formation of glycosylated protein denaturation products
10/08/1998	WO1998043640A1 Benzocycloheptathiophene compounds
10/08/1998	WO1998043612A1 Use of sodium channel blocker in the manufacture of a medicament for preventing optic nerve degeneration associated with glaucoma
10/08/1998	CA2285372A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
10/08/1998	CA2284940A1 Use of sodium channel blocker in the manufacture of a medicament for preventing optic nerve degeneration associated with glaucoma
10/07/1998	EP0869126A1 Dithiolan derivatives, their preparation and their therapeutic effect
10/07/1998	EP0868434A1 Anti-idiotypic antibodies of vascular endothelial growth factor and use thereof as drugs
10/07/1998	EP0868186A1 Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia
10/07/1998	EP0724566B1 1,2-diarylcyclopentenyl compounds for the treatment of inflammation
10/07/1998	CN1195340A Inhibitors of farnesyl-protein transferase
10/07/1998	CN1195295A Method and use of connective tissue growth factor as revellent
10/07/1998	CN1195294A Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligang antibodies, as therapeutic agents for treatment of immunological disease
10/06/1998	US5817631 Therapeutic uses of melanin
10/02/1998	CA2233682A1 Dithiolan derivatives, their preparation and their therapeutic effect
10/01/1998	WO1998042738A1 87 human secreted proteins
10/01/1998	WO1998042379A2 Chemically and thermally stable norastemizole formulations
10/01/1998	WO1998042357A1 Use of an extract of alchemilli vulgaris
10/01/1998	WO1998042313A1 Opthalmic non-irritating iodine medicament and method
10/01/1998	CA2284705A1 Chemically and thermally stable norastemizole formulations
10/01/1998	CA2284696A1 Opthalmic non-irritating iodine medicament and method
10/01/1998	CA2284550A1 87 human secreted proteins
09/1998
09/30/1998	EP0866803A1 Transferrin receptor protein of moraxella
09/30/1998	EP0866719A1 Method for treating retinal ganglion cell injury using glial cell line-derived neurotrophic factor (gdnf) protein product
09/30/1998	EP0866716A1 Methods of treating disorders of non-visual sensory epithelia
09/30/1998	EP0866691A1 Sublingual and buccal administration of selegiline
09/30/1998	EP0577646B1 Sustained release drug delivery devices
09/30/1998	CN1194581A Use of adamantan derivatives for treating diseases of inner ear
09/29/1998	US5814657 1,3-benzodioxole and 1,2-dialkoxybenzene derivatives as ocular hypotensive agents
09/29/1998	US5814620 Inhibition of neovascularization using vegf-specific oligonucleotides
09/29/1998	CA2100503C Piperidine derivatives of benzimidazole
09/24/1998	WO1998041542A1 Antiangiogenic drug to treat cancer, arthritis and retinopathy
09/24/1998	WO1998041208A1 Compositions and methods for reducing ocular hypertension
09/24/1998	WO1998041092A1 Novel indolecarboxamides, pharmaceutical compositions and methodsof inhibiting calpain
09/23/1998	EP0865789A2 Pharmaceutical compositions for intranasal administration of dihydroergotamine
09/23/1998	EP0865421A1 Arylethanolamine derivatives and their use as agonists of atypical beta-adrenoceptors
09/23/1998	EP0865339A1 Metalloproteinase inhibitors
09/23/1998	CN1193978A Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases
09/23/1998	CN1193911A Use of basic amino acids and derivatives for lowering ceramide levels
09/22/1998	US5811553 Quinoline derivatives(2)
09/22/1998	US5811549 Process of preparing imidazole compounds
09/22/1998	US5811453 Viscoelastic compositions and methods of use
09/22/1998	US5811443 Side effect reduction
09/22/1998	US5811438 Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory products
09/17/1998	WO1998040488A1 Anti-alphabeta3 humanized monoclonal antibodies
09/17/1998	WO1998040482A1 Growth factor receptor binding protein
09/17/1998	CA2284518A1 Anti-alphabeta3 humanized monoclonal antibodies
09/17/1998	CA2283296A1 Growth factor receptor binding protein
09/16/1998	EP0864653A1 Process for production of 4-(4-(4-(hydroxydiphenyl)-1-piperidinyl)-1-hydroxybutyl)-alpha, alpha-dimethylphenyl acetic acid and phosphorylated derivatives
09/16/1998	EP0864323A1 Pharmaceutical preparation for oral application containing a histamine-immunoglobulin complex
09/16/1998	EP0864087A1 Combinatorial dihydrobenzopyran library
09/16/1998	EP0863883A1 Alpha-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors
09/16/1998	EP0863875A1 New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency
09/16/1998	EP0863873A1 Indole carbamates as leukotriene antagonists
09/16/1998	EP0863766A1 Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (gdnf) protein product
09/16/1998	EP0863729A1 Implantable controlled release device to deliver drugs directly to an internal portion of the body
09/16/1998	EP0728128B1 Substituted phenyl compounds
09/16/1998	CN1192929A Oral medicinal preparation
09/16/1998	CN1192914A Fuming capsule and preparing method thereof
09/15/1998	US5807818 Therapeutic uses of bactericidal/permeability increasing protein (BPI) protein products
09/15/1998	US5807731 Antitumor
09/11/1998	WO1998039329A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds
09/11/1998	WO1998039293A2 13-thia prostaglandins for use in glaucoma therapy
09/11/1998	WO1998039015A1 Opthalmic composition
09/11/1998	WO1998038859A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
09/11/1998	WO1998030707A3 Eukaryotic gene expression cassette and uses thereof
09/11/1998	CA2285405A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds
09/11/1998	CA2283275A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
09/11/1998	CA2283272A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds
09/11/1998	CA2283145A1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
09/11/1998	CA2282399A1 Thioaryl sulfonamide hydroxamic acid compounds
09/11/1998	CA2282318A1 N-hydroxy 4-sulfonyl butanamide compounds

1 ... 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 ... 531